只使用免费官方源：SEC Forms 3/4/5 结构化内部人申报，以及 FINRA Consolidated NMS 场外卖空成交量。 两类数据均保留来源边界，不转写成买卖建议。
SEC 已完成季度 Forms 3/4/5 结构化历史基线 + EDGAR 当前季度 Form 4 增量；个股卡片仅展示当前自然季度的非衍生证券买卖代码 P/S（公开市场或私下交易），成交金额由股数 × 每股价格计算。
官方数据说明| 2026-05-15 2026-05-18 | EHC Encompass Health Corp | COLTHARP DOUGLAS E Officer · EVP & Chief Financial Officer | 卖出（S） | 27,693 | US$106.83 | US$295.84万 | 69,378 | SEC |
| 2026-05-12 2026-05-13 | GEHC GE HealthCare Technologies Inc. | Hochman Rodney F Director | 买入（P） | 1,618 | US$62.03 | US$100,364.54 | 1,618 | SEC |
| 2026-05-11 2026-05-12 | EHC Encompass Health Corp | Tuer Patrick William Officer · EVP, Chief Operating Officer | 卖出（S） | 682 | US$104.56 | US$71,309.92 | 24,755 | SEC |
| 2026-05-08 2026-05-11 | GEHC GE HealthCare Technologies Inc. | Yang Watkin Phoebe L. Director | 买入（P） | 1,000 | US$63.01 | US$63,010.00 | 13,702 | SEC |
| 2026-05-06 2026-05-07 | GEHC GE HealthCare Technologies Inc. | CULP H LAWRENCE JR Director | 买入（P） | 80,805 | US$61.88 | US$500.02万 | 151,207 | SEC |
| 2026-05-06 2026-05-07 | GEHC GE HealthCare Technologies Inc. | Stromberg William J Director | 买入（P） | 1,000 | US$61.69 | US$61,690.00 | 15,330 | SEC |
| 2026-05-01 2026-05-01 | GEHC GE HealthCare Technologies Inc. | SACCARO JAMES Officer · Chief Financial Officer | 买入（P） | 3,310 | US$60.60 | US$200,586.00 | 87,471 | SEC |
| 2026-04-30 2026-04-30 | GEHC GE HealthCare Technologies Inc. | Arduini Peter J Director,Officer · President and CEO | 买入（P） | 4,169 | US$59.93 | US$249,848.17 | 259,424 | SEC |
| 2026-04-30 2026-04-30 | GEHC GE HealthCare Technologies Inc. | Jimenez Frank R Officer · GC & Corporate Secretary | 买入（P） | 1,750 | US$60.45 | US$105,787.50 | 93,932 | SEC |
| 代码 | 卖空成交量 | 豁免卖空量 | 场外总成交量 | 卖空量占比 | 报告设施 |
|---|---|---|---|---|---|
| EHC | 104,575.356 | 278 | 184,572.3926 | 56.66% | B, Q, N |
| GEHC | 895,036.1397 | 754 | 1,704,909.3341 | 52.50% | B, Q, N |
| EHCC | 4 | 0 | 14.1028 | 28.36% | Q |